Print Magazine
Brussels Morning Newspaper
Monday, May 16, 2022
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home Brussels

Professor who laid the foundation for COVID vaccines receives Solvay science prize

Helen Critchley by Helen Critchley
30 March 2022
in Brussels
Professor who laid the foundation for COVID vaccines receives Solvay science prize
Share on FacebookShare on Twitter

BRUSSELS (Brussels Morning) – Hungarian professor Katalin Karikó received the science prize from the chemical company Solvay on Tuesday in the Palace of the Academies in Brussels. With her years of research into mRNA technology, she laid the foundation for various corona vaccines. The Science for the Future Solvay Prize, as it is officially called, is worth 300,000 euros.

​​​​​​”It is an incredible honour to receive this award,” says Karikó. “Thanks to many teachers and professors, I got to know the beauty of chemistry at university. I want to thank them for that, and I also thank my family, all my colleagues and the jury.”

Karikó, adjunct professor at the University of Pennsylvania (USA) and professor at the University of Szeged (Hungary), “has devoted her 40-year career to the use of RNA as a therapeutic agent,” says Solvay, “with chemistry as a key element to synthesise the mRNA to avoid the risk of rejection by the immune system”.

Messenger RNA or mRNA has been a commonly used term since the corona pandemic. It is described as the genetic script that passes on DNA instructions to each cell to form proteins, thus instructing the body to make its own medicine.

Other Applications

Pfizer/BioNTech’s corona vaccines are not the first application of mRNA technology in medicine.

“As early as 2018, AstraZeneca and Moderna conducted human clinical trials in the fight against heart failure, and tests were already being conducted with mRNA vaccines against flu,” says Karikó.

“Messenger RNA can also be used for the development of vaccines that do not yet exist, such as against HIV and of course cancer. There are currently about 150 clinical studies with mRNA. We are hopeful that effective drugs can be developed quickly.”

Essential Role

The Hungarian scientist is the second woman to win the Solvay science prize. The prize, which has been in existence since 2013, honours a scientist “for significant discoveries that underscore the vital role of science and chemistry in helping to solve some of the world’s most pressing challenges.”

Karikó also received an honorary doctorate from the Université libre de Bruxelles (ULB) last week for her groundbreaking work.

Tags: COVIDFeaturedMain-SliderProfessorSolvay Prizevaccines

Latest post

Launch,of,the new European-Parliament,logo

European Parliament look ahead — Ukraine, Fit for 55, digital single market, Moldova

11 hours ago
Overturning Roe v. Wade Will Reveal Our Flawed Constitution

Overturning Roe v. Wade Will Reveal Our Flawed Constitution

3 days ago

Most Read

  • shutterstock_1821616664

    MEPs send Open Letter urging the Home Secretary Priti Patel to reject Assange’s extradition

    0 shares
    Share 0 Tweet 0
  • These are the 10 highest paying jobs in the Europe in 2022

    0 shares
    Share 0 Tweet 0
  • Brussels residents want to set up school for Ukrainian children

    0 shares
    Share 0 Tweet 0
  • Why corruption matters

    0 shares
    Share 0 Tweet 0
  • Sweden: Taking Syrian children away from parents for protection?

    0 shares
    Share 0 Tweet 0
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Belgium News
  • Brussels
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Print Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT